Van Eck Associates Corp Vascular Biogenics Ltd. Transaction History

Van Eck Associates Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$0.6 - $1.72 $5,234 - $15,005	-8,724 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$1.55 - $2.17 $775 - $1,085	500 Added 6.08%	8,724 $14,000
Q2 2018 Aug 13, 2018	BUY	$2.05 - $3.0 $10,420 - $15,249	5,083 Added 161.83%	8,224 $18,000
Q1 2018 May 11, 2018	BUY	$2.27 - $8.5 $476 - $1,785	210 Added 7.16%	3,141 $7,000
Q4 2017 Feb 12, 2018	SELL	$5.65 - $9.0 $19,622 - $31,257	-3,473 Reduced 54.23%	2,931 $21,000
Q3 2017 Nov 09, 2017	BUY	$4.15 - $7.2 $1,186 - $2,059	286 Added 4.67%	6,404 $39,000
Q2 2017 Aug 11, 2017	BUY	N/A	6,118	6,118 $27,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.